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The objectives of the present study were to characterize the P2X receptor-mediated cellular contractile and Ca 2ϩ transient effects and to determine the mechanism underlying the receptor-induced increase in myocyte contractility. Tg mice were used as a model for the current objectives. The data showed that activation of the cardiac P2X 4 receptor led to an enhanced myocyte contraction shortening (CS) and Ca 2ϩ transients. The P2X receptor-mediated increase in myocyte contractility occurred in the absence of any change in cAMP level or L-type Ca 2ϩ channel activity and did not involve any change in the sensitivity to intracellular Ca 2ϩ . An increased sarcoplasmic reticulum (SR) Ca 2ϩ store is the principal mechanism responsible for the enhanced contractile state induced by this receptor channel.
MATERIALS AND METHODS

Isolation of adult mouse cardiac ventricular myocytes from P2X4
receptor Tg mice. Ventricular myocytes were obtained from 3-mo-old P2X 4R transgenic (Tg) or wild-type (WT) mice by an enzymatic dissociation procedure as described previously (21, 29) . The study was approved by the IACUC at the University of Connecticut Health Center. The hearts were rapidly excised from mice that had been anesthetized with pentobarbital and treated with 1,000 U of heparin. The aorta was cannulated and the heart perfused in a Langendorff apparatus with oxygenated (95% O 2-5% CO2) Ca 2ϩ -free solution (37°C) for 5 min at a rate of 2.5 ml/min. The solution composition was (in mM) 126 NaCl, 4.4 KCl, 1.0 MgCl 2, 18 NaHCO3, 11 glucose, 4 HEPES, and 3 BDM (2,3-butanedione monoxime) (pH 7.3 adjusted with NaOH). Thereafter, the perfusing solution was changed to one containing 25 M CaCl 2 and liberase (70 g/ml, Roche Molecular Biochemicals) for 8 -10 min. Cells were then exposed to a stepwise increase in extracellular Ca 2ϩ from 0.025, 0.2, and then 1.0 mM, allowed to settle for 30 min at room temperature, and finally suspended with Tyrode's solution containing (in mM) 135 NaCl, 5.4 KCl, 1.0 CaCl 2, 1.0 MgCl2, 10 HEPES, and 10 dextrose (pH 7.4 adjusted with NaOH). The experiments were carried out at room temperature (22-23°C) and were completed within 4 -6 h after myocyte isolation.
Electrophysiological recordings. Action potentials were elicited at 0.5 Hz in current-clamp mode. Myocytes were superfused with normal Tyrode's solution. The pipette was filled with a solution containing (in mM) 120 potassium aspartate, 30 KCl, 5 Na2ATP, 1 MgCl 2, 5 HEPES, and 10 EGTA (pH was adjusted to 7.3 with KOH).
L-type Ca 2ϩ current was measured by the whole cell patch-clamp technique. The patch electrodes were prepared from borosilicate glass pipette (1.2 mm ID) with a two-step pulling procedure and had a resistance of 2-4 M⍀ when filled with a solution containing (in mM) 135 cesium aspartate, 5 NaCl, 5 Mg 2ATP, 10 HEPES, and 10 EGTA (pH 7.3 adjusted with CsOH). As soon as electrical contact was established, the superfusion medium was changed to a modified Tyrode's solution (5.4 mM KCl was omitted and 10 mM CsCl was added to Tyrode's solution) to block K ϩ currents. Generation of voltage clamp protocols and acquisition of data were carried out with pCLAMP software (version 7; Axon Instruments). Sampling frequency was 10 kHz. The voltage-clamp protocol used to elicit the current-voltage relation was a series of 300-ms steps of increasing voltage, from Ϫ30 to ϩ60 mV in 10-mV increments at a frequency of 0.2 Hz. Each step was preceded by a 300-ms step from a holding potential of Ϫ80 to Ϫ40 mV that inactivated the fast Na ϩ current and T-type Ca 2ϩ current. Estimation of SR Ca 2ϩ content. The Ca 2ϩ content of the SR was obtained from experiments with caffeine. The experimental conditions of recording Na ϩ /Ca 2ϩ exchange current (INa/Ca) was similar to L-type Ca 2ϩ current experiment except that EGTA in the pipette was reduced to 0.5 mM. The outlet of the rapid solution device (SF-77B, Warner Instrument) was brought within 50 m of the cell. After recording conditions for the cell had stabilized, Tyrode's solution, identical to the bath solution, was applied to the cell by using the rapid solution device. Three 300-ms conditioning stimuli (Ϫ80 to ϩ50 mV) at 0.2 Hz were applied to cells. At 2 s after the last stimulus, the perfusion was rapidly changed to a solution containing 10 mM caffeine for 10 s. With the membrane held at Ϫ80 mV, the Ca 2ϩ released by caffeine induced a large inward current via the Na/Ca exchanger; this current represented the basal control SR Ca 2ϩ content (3). Integration of this inward current provides an estimate of SR Ca 2ϩ content (25) . Baseline of the current was defined as that measured at ϳ2,500 ms from the peak current and was used for current transient integration. After a control test with caffeine, 2-me-SATP (3 M) was applied for 3 min. Caffeine was rapidly superfused again after three conditioning stimuli were delivered under conditions identical to those for the basal SR Ca 2ϩ content determination. Data were taken only from those cells that could be held during the control period, in the presence of 2-meSATP and after washout. The caffeineinduced inward current via the Na/Ca exchanger has been used previously to estimate the SR Ca content in adult mouse ventricular myocytes (24, 30) .
Another method to estimate the SR Ca 2ϩ content is to measure the amplitude of the caffeine-induced Ca 2ϩ transients (7, 9) . In these experiments, Tg or WT myocytes were field stimulated at 0.2 Hz for 5 min and then 10 mM caffeine was rapidly applied for 10 s. The amplitude of Ca 2ϩ transient was recorded as the basal SR Ca 2ϩ content. Five minutes after washout of caffeine, 3 M 2me-SATP was applied for 5 min while the myocytes were continuously paced at 0.2 Hz. This was then followed by the same brief exposure to caffeine in the presence of 2-meSATP and the Ca 2ϩ transients were recorded. The same procedure was repeated during washout of 2-meSATP.
Determination of CS, cAMP, and Ca 2ϩ transients in isolated cardiac myocytes. Myocyte CS by changes in sarcomere length and Ca 2ϩ transients were recorded simultaneously from single isolated myocytes with an epifluorescence inverted microscope with Ionoptix software and camera (Ionoptix, Milton, MA) as previously described (5, 6, 10, 12) . Cells were superfused with Tyrode's solution at 25°C and field stimulated as previously described (21) . Ca 2ϩ transients were measured with the ratiometric dye fura 2-AM. Myocytes were loaded with 2 M of fura 2-AM for 20 min at 25°C. Ca 2ϩ transients were recorded as the fluorescence ratio at 510 nm in response to excitation from 340 and 380 nm. Ca 2ϩ transients were digitized and analyzed. Ca 2ϩ transients and CS were measured simultaneously in the same myocytes. The background fluorescence, determined by measuring and averaging the autofluorescence of randomly selected 6 -9 myocytes not loaded with fura 2, was subtracted. Steady-state recordings were measured under baseline control conditions and after exposure to 2-meSATP. Various CS and Ca 2ϩ transient parameters such as amplitude, maximal rates of rise and fall, time to 50% peak, and time to 50% decline were measured with Ionoptix curve-fitting algorithm software as previously described (5, 6, 12, 13) .
Cyclic AMP was determined with an enzymatic immunoassay kit according to manufacturer's instructions, similar to the method used to estimate cAMP level in dispersed mammalian cardiac ventricular myocytes (28, 14) . In brief, myocytes were isolated and plated in a 96-well plate at a density of 10 3 cells/well. Following a 1-h equilibration, myocytes were incubated with either vehicle or 2-meSATP (10 M) or isoproterenol (0.1 M) for 10 min and then lysed. cAMP measurements were made with the GE Healthcare cAMP Direct Biotrak Enzyme Immuno Assay Kit according to manufacturer's instructions.
Statistical analysis. Data were presented as means Ϯ SE. The significance of differences between means was analyzed with appropriate analysis of variance and posttest comparison by Newman-Keuls test. Values with P Ͻ 0.05 were considered statistically significant. In other comparisons, a paired t-test was used.
Drugs and solutions. 2-meSATP and ATP were obtained from Sigma Chemical (St. Louis, MO). Fura 2-AM was obtained from Molecular Probes (Eugene, OR) and used according to manufacturer's instructions as previously described (5, 6, 10, 12) . cAMP EIA kit was from GE Healthcare (Piscataway, NJ). The P2X 4R transgenic construct was generated and bred as previously described (8) .
RESULTS
Characteristics of cardiac P2X receptor-mediated increase in myocyte contraction shortening and intracellular Ca 2ϩ
transients. Activation of the P2X receptor caused an increased contractile state of cardiac myocytes from the P2X 4 receptor Tg animals. The basal CS amplitude in the Tg myocyte was similar to that of WT cardiac myocytes (8) . Myocytes from the Tg heart were used as model to characterize the cardiac P2X receptor-mediated increase in CS and Ca 2ϩ transient. The contractile parameters and Ca 2ϩ transient at control and in response to the P2X agonist 2-meSATP were characterized in these myocytes. Data in Fig. 1 , A and C, showed a simultaneous measurement of Ca 2ϩ transient and CS in a Tg cardiac myocyte. 2-meSATP caused a concomitant increase in CS and Ca 2ϩ transient. When the CS and Ca 2ϩ transient were normalized to their maximal amplitudes, the normalized fluorescence ratio and CS obtained during control and 2-meSATP stimulation were superimposable (Fig. 1, B and D) . Although 2-meSATP caused a significant increase in CS (P Ͻ 0.05), the maximal rates of contraction shortening and relaxation, the time to 50% peak, and the time to 50% relengthening were similar under control and 2-meSATP conditions (P Ͼ 0.1, n ϭ 9 myocytes, Table 1 ). Similarly, the P2X agonist-stimulated increase in Ca 2ϩ transient was not associated with any alteration in the maximal rates of rise or fall of the fluorescence ratio (P Ͼ 0.1, n ϭ 9 myocytes, Table 2 ). The time to 50% peak and time to 50% decline of the fluorescence ratio under control conditions were the same as those obtained in the presence of 2-meSATP (P Ͼ 0.1, Table 2 ). The various CS and Ca 2ϩ transient parameters were similar to those in WT cardiac myocytes reported by others (9 -11, 23) . In adult ventricular myocytes of WT mice, 2-meSATP was also able to cause an increase in the CS (basal: 0.071 m Ϯ 0.013 m; 2-meSATP: 0.086 m Ϯ 0.013 m, n ϭ 4 myocytes, 0.2 Hz, P ϭ 0.04, paired t-test) and Ca 2ϩ transient amplitude (basal ratio: 0.058 Ϯ 0.006; 2-meSATP: 0.067 Ϯ 0.006, 0.2 Hz, P ϭ 0.026, paired t-test). Similar to data obtained in Tg myocytes, the times to 50% peak and to 50% relengthening were similar in the presence or the absence of 2-meSATP (P Ͼ 0.1). The times to 50% peak and to 50% decline of fluorescence ratio under basal condition were also similar to those obtained in the presence of 2-meSATP (P Ͼ 0.1). The proportion of WT myocytes (4 of 17 myocytes from 10 mice) showing an increase in CS and Ca 2ϩ transient was similar to that reported previously (21) . These data indicate that the P2X receptorinduced stimulation of CS and Ca 2ϩ transient was limited to only an increase in the amplitude, without any change in other characteristics of these two physiological parameters.
Cardiac P2X receptor-mediated increase in myocyte contractility is associated with a concomitant increase in intracellular Ca 2ϩ transients. P2X 4 R Tg cardiac myocytes demonstrated a significant increase in the extent of contraction shortening (CS) in response to extracellular 2-meSATP at 0.2 and 1.0 Hz ( Fig. 2A) 2-meSATP ϭ 0.052 Ϯ 0.01 m, P Ͻ 0.05). The extent of CS was reduced under basal and 2-meSATP-stimulated conditions at higher stimulation rates (Fig. 2B) . (2) . In the present study, the fura 2 Ca 2ϩ fluorescence and CS obtained at 2 Hz were similar to those obtained at 1 Hz, similar to those reported previously (2) . In comparing the change in CS with that in Ca 2ϩ fluorescence ratios, the P2X receptor-mediated increase in CS was associated with an increase in the intracellular Ca 2ϩ transients, assessed as fluorescence ratios at various frequencies of pacing (Fig. 2, A and B (Fig. 2C) . The slope without extracellular 2-meSATP (0.21 Ϯ 0.036) was similar to that with 2-meSATP (0.20 Ϯ 0.02, P Ͼ 0.1). The data indicate that the agonist-induced increase in myocyte contractility was not due to an increase in sensitivity to intracellular Ca 2ϩ .
Stimulatory effect of extracellular 2-meSATP on SR Ca 2ϩ
content in P2X 4 R Tg myocytes. The P2X receptor-mediated increase in Ca 2ϩ transients may be the result of an enhanced SR Ca 2ϩ store during receptor activation. To test this hypothesis, caffeine-induced inward I Na/Ca was used to determine the SR Ca 2ϩ content in the absence and the presence of P2X agonist. Fig. 3A showed that the presence of extracellular 2-meSATP caused a significant increase in the caffeine-induced inward current in 10 of 16 Tg myocytes (P Ͻ 0.05). The increase was significant in both the peak (Fig. 3A) and the integrated (Fig. 3B ) I Na/Ca inward current in these myocytes (P Ͻ 0.05 vs. the basal control level). Similarly, 2-meSATP was also able to induce significant increases in caffeine-evoked inward current in 5 of 13 WT cardiac myocytes (P Ͻ 0.05 vs. the basal control level) (Fig. 3, A and B) . In general, more P2X 4 R Tg than WT myocytes showed a response to extracellular 2-meSATP (21) . The proportions of 2-meSATP-responsive Tg and WT cells in the present study were similar to those reported previously (21) . The P2X receptor agonist effect dissipated upon its washout in both WT and Tg myocytes. The increased caffeine-mediated inward I Na/Ca by 2-meSATP in P2X 4 R Tg myocytes was not due to an increased density of the Na ϩ /Ca 2ϩ exchanger in the Tg myocyte since the peak and the integrated I Na/Ca currents under basal agonist-free condition in Values are means Ϯ SE; 9 Tg cardiac myocytes were stimulated at 0.2 Hz, *P Ͻ 0.05 (paired t-test) . The rates of rise and fall of fluorescence ratios were presented as fluorescence unit per second (U/s). , n ϭ 5 myocytes, P Ͼ 0.1 vs. Tg myocytes). Activation of native cardiac P2X receptors on WT myocytes was also able to increase caffeine-evoked inward current (Fig. 3, B and C) . The data further support the concept that the caffeine-induced I Na/Ca by P2X agonist is likely due to an enhanced loading of the SR with Ca 2ϩ . The caffeine-induced Ca 2ϩ transient amplitude was also used to estimate the SR Ca 2ϩ content in both the Tg and the WT myocytes. Data summarized in Fig. 4 showed that under the control condition without any agonist, a brief caffeine exposure caused a large Ca 2ϩ transient secondary to its release from the SR. The amplitude of Ca 2ϩ transient represented the basal SR Ca 2ϩ store in the Tg (Fig. 4, right) and WT (left) myocytes. However, in the presence of 2-meSATP, the caffeine-induced Ca 2ϩ transient was significantly greater than that obtained under the basal control condition in both the Tg and the WT myocytes (Fig. 4) The P2X receptor-mediated increase in myocyte contractility or Ca 2ϩ transient occurred in the absence of any cAMP accumulation in the P2X 4 R Tg myocyte. 2-meSATP did not cause any increase in the intracellular cAMP level (Fig. 5) . The basal cAMP level was 3.97 Ϯ 0.33 pmol/mg protein and was similar to that obtained in the presence of 2-meSATP at 10 M (3.18 Ϯ 0.45 pmol/mg, P Ͼ 0.1). The cAMP level increased to 16.6 Ϯ 1.53 pmol/mg in the presence of isoproterenol (P Ͻ 0.05 vs. basal or 2-meSATP, n ϭ 12 determinations from myocytes of three Tg mice, Ϯ SE). Additionally, 2-meSATP also did not increase cAMP accumulation in WT cardiac myocytes (basal: 1.89 Ϯ 0.21 pmol/mg, Ϯ SE, vs. 2-meSATP: 2.36 Ϯ 0.36 pmol/mg, P Ͼ 0.1, n ϭ 32 determinations from myocytes of six mice). Isoproterenol increased the cAMP level to 8.47 Ϯ 1.15 pmol/mg in WT myocytes (P Ͻ 0.05 vs. basal or 2-meSATP). Given the known effect of cAMP on L-type Ca 2ϩ channel activity, the lack of any stimulatory effect of 2-meSATP on cAMP accumulation is compatible with its lack Fig. 2 . Cardiac P2X receptor-mediated increases in myocyte contractility and Ca 2ϩ transient. Cardiac ventricular myocytes were prepared from P2X4R Tg hearts. CS and Ca 2ϩ transients were measured as described in the legend to Fig. 1. A and B: in response to 2-meSATP (3 M), both the CS and Ca 2ϩ transient increased significantly compared with the basal control (CTR) levels at 0.2 Hz, 0.5 Hz, 1.0 Hz pacing frequency (n ϭ 9 myocytes from 8 mice, *P Ͻ 0.05, **P Ͻ 0.01 vs. CTR). Consistent with a negative force-frequency relationship in adult mouse myocytes, the CS and Ca 2ϩ transients decreased with increasing heart rates (B). C: plot of the change in Ca 2ϩ fluorescence vs. that in CS before exposure to the P2X agonist 2-meSATP was identical to the plot obtained after agonist stimulation. Slopes were similar in the 2 plots (P Ͼ 0.1). Data are means Ϯ SE. Fig. 3 . Cardiac P2X receptor can mediate an increased sarcoplasmic reticulum (SR) Ca 2ϩ store. Cardiac ventricular myocytes were prepared from wild-type (WT) and P2X4R Tg hearts. SR Ca 2ϩ content was quantified by the caffeine (Caff; 10 mM)-induced inward current mediated via the Na ϩ /Ca 2ϩ exchanger as described in MATERIALS AND METHODS. A: in the presence of extracellular 2-meSATP (3 M), the caffeineinduced inward current increased significantly. The tracings were from 1 typical Tg myocyte representative of 10 cardiac myocytes from 7 mice, P Ͻ 0.05. A similar tracing was obtained in WT cardiac myocytes in response to extracellular 2-meSATP and caffeine (not shown). In both WT and TG cardiac myocytes, the peak (B) and the integrated (C) inward current were increased by 2-meSATP (P Ͻ 0.05) compared with the CTR level, indicating a SR Ca 2ϩ loading effect via the cardiac P2X receptor. The SR Ca 2ϩ loading effect dissipated upon washout (WO) or removal of 2-meSATP. All data were provided as means Ϯ SE of 5 WT (from 4 mice) and 10 Tg myocytes that responded to extracellular 2-meSATP. *P Ͻ 0.05 vs. CTR or WO.
of stimulation of the L-type Ca 2ϩ channel, as reported previously (21) .
Effects of 2-meSATP on action potential duration, resting membrane potential, and L-type Ca 2ϩ current. To further characterize the effects of cardiac P2X receptor activation, Tg myocytes overexpressing P2X 4 receptors were exposed to 2-meSATP, and action potential duration at 50 and 90% of repolarization (APD 50 and APD 90 , respectively) and membrane potential were determined. The P2X agonist did not cause any change in the APD 50 or APD 90 (Fig. 6A and Table  3 ) or the resting membrane potential (Table 3 ). In WT mouse ventricular myocytes, 2-meSATP also did not induce any change in membrane potential (Ϫ70 Ϯ Ϫ1.97 vs. Ϫ69.9 Ϯ Ϫ2.45 mV with 2-meSATP, Ϯ SE, n ϭ 4 myocytes, P Ͼ 0.1), APD 50 (15.9 Ϯ 6.43 vs. 16.3 Ϯ 6.13 ms with 2-meSATP) or APD 90 (55.6 Ϯ 13.92 vs. 54.21 Ϯ 12.83 ms with 2-meSATP). APD 90 appeared longer in Tg than in WT myocytes, owing to inclusion of 2 Tg myocytes with much longer action potential duration (Fig. 6A) . Although changes in the action potential waveform and duration can alter the amplitude of Ca 2ϩ transient (4, 19) , the present data suggest that the 2-meSATP-induced increase in Ca 2ϩ transient was not associated with any detectable alteration in the action potential duration or characteristics in the P2X 4 receptor Tg or the WT Isoproterenol caused a large increase in the cAMP level (*P Ͻ 0.05 vs. basal or 2-meSATP, 1-way ANOVA and posttest comparison) whereas 2-meSATP had no effect on the basal cAMP level (P Ͼ 0.05). Data were means Ϯ SE of 12 determinations from myocytes of 3 Tg mice. Resting potential and action potential duration at 50 and 90% of repolarization (APD50 and APD90, respectively) were determined by using the current-clamp mode in 6 Tg cardiac myocytes as described in MATERIALS AND METHODS.
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CARDIAC P2X RECEPTOR AND CONTRACTILITY cardiac myocyte. Activation of the overexpressed P2X 4 receptor did not change the L-type Ca 2ϩ current at any of the voltages tested. The current-voltage relation of the L-type Ca 2ϩ channel in the Tg myocyte was similar whether or not 2-meSATP was present (Fig. 6B) .
DISCUSSION
Activation of cardiac P2X receptors is capable of enhancing the contractile state of the myocyte and intact heart (8, 15, 29) . Little is known regarding the mechanism of P2X receptormediated increase in contractility. By using transgenic mice with cardiac-specific overexpression of P2X 4 receptors as a model, the present data show that an increased SR Ca 2ϩ loading, occurring independent of any change in the cAMP level or the activity of L-type Ca 2ϩ channel, is the mechanism of P2X receptor-mediated increase in contractility.
Of the P2X receptor subfamily, the P2X 4 receptor is an important subunit of the cardiac myocyte P2X receptor (21) . Cardiac myocytes isolated from transgenic mice with cardiacspecific overexpression of the P2X 4 receptor were developed as a model to investigate the mechanism of enhanced contractility. A number of lines of evidence indicate that the mechanism of this enhanced contractile state is the result of an increased SR Ca 2ϩ loading via activation of this receptor channel by extracellular ATP. First, activation of the overexpressed P2X 4 receptor by the P2X agonist 2-meSATP caused an increased intracellular Ca 2ϩ transient. This increase in cellular Ca 2ϩ transient was temporally associated with the increase in myocyte contractility. Second, activation of the receptor channel in P2X 4 R Tg myocytes increased the caffeine-induced I Na/Ca inward current in the presence of extracellular 2-meSATP. This increase in I Na/Ca current in the Tg myocyte was not due to an increased I Na/Ca density in the Tg myocyte since the latter has a similar basal I Na/Ca density as the WT myocytes. In WT cardiac myocytes, extracellular 2-meSATP induced a caffeine-evoked inward current, indicating that activation of the endogenous cardiac P2X receptor in WT myocyte can also increase SR Ca 2ϩ store. Thus the increased I Na/Ca current was the result of an increased SR Ca 2ϩ store. Further evidence for a SR Ca 2ϩ loading effect of the overexpressed P2X 4 receptor was provided by significantly larger amplitude of caffeine-induced Ca 2ϩ transient in the presence of P2X agonist than that obtained in the absence of the agonist in both the Tg and the WT myocytes. Third, the relationship between the change in CS and that of intracellular Ca 2ϩ was the same before and after P2X agonist application. The slopes were virtually identical. Changes in myofilament Ca 2ϩ sensitivity can manifest as alterations in the duration of contraction (23) . If P2X receptor activation could alter myofilament Ca 2ϩ sensitivity, the presence of 2-meSATP would have changed the duration of contraction. However, data summarized in Fig. 1D and Table 1 showed that this was not the case. Overall, the data suggest that activation of the overexpressed P2X 4 receptor did not change sensitivity to cellular Ca 2ϩ , suggesting against the possibility that an enhanced Ca 2ϩ sensitivity was the mechanism of receptor-induced contractility increase. Fourth, our previous study demonstrated that activation of the native or the overexpressed cardiac P2X receptors had no effect on the L-type Ca 2ϩ channel current (21) . In the present study, activation of the overexpressed P2X 4 receptor had no effect on the L-type Ca 2ϩ current. In the Tg myocyte, the L-type Ca 2ϩ current-voltage relation in the presence of 2-meSATP was the same as that obtained in its absence. The data ruled out an increased L-type channel activity as a cause of the increased myocyte contractility via P2X receptors. That the agonist-induced increase in Tg myocyte contractility was not associated with any cAMP increase is consistent with a lack of effect of P2X receptor activation on the L-type Ca 2ϩ channel. The increase in cardiac myocyte contractility induced by the overexpressed P2X 4 receptor was not associated with any change in the time to peak, the maximal rate of shortening or of relaxation, or the time to 50% relengthening. Similarly, the receptor-mediated increase in Ca 2ϩ transient also did not cause any alteration in the diastolic Ca 2ϩ , the maximal rates of rise or decline, the time to 50% peak, or the time to 50% decline of the fluorescence ratio. The lack of any effect on the rates of shortening and relaxation of CS or those of Ca 2ϩ transient is consistent with an absence of an increase in cAMP level since cAMP is known to accelerate the rate of rise and relaxation with a shortening effect on the duration of both contraction and Ca 2ϩ transients (11, 27) . The P2X receptormediated increase in Ca 2ϩ transient was not due to any change in the action potential duration or characteristics since 2-meSATP had no effect on the APD 50 , APD 90 , or the resting membrane potential of the Tg cardiac myocyte. That the P2X 4 receptor Tg myocytes showed a similar SR Ca 2ϩ -ATPase activity and SERCA2a and phospholamban levels as the WT cardiac myocytes suggests against an increased SR uptake as the mechanism for the enhanced SR Ca 2ϩ loading effect of P2X receptor. The exact mechanism by which activation of the overexpressed P2X 4 receptor leads to an increase SR store is not known but deserves future investigation. The 2-meSATP-induced increase in the contractility of WT myocytes was also not accompanied by any change in the rates of rise and decline of contraction or Ca 2ϩ transient or the duration of action potential. These data further support the validity of findings in the P2X 4 receptor-overexpressing Tg myocytes. These Tg myocytes represent a useful model to study the cardiac P2X receptor action and mechanism.
The stimulatory effect of P2X receptor agonist on Ca 2ϩ transient was confined to that on the systolic but not the diastolic level. The lack of any effect on the diastolic Ca 2ϩ level should not result in any increase in contractile state during diastole. This property would avoid a negative lusitropic effect and should permit the manifestation of a greater ϪdP/dt in the intact heart contractility measurement that was observed in previous studies (8, 15) . Overall, the cardiac myocyte P2X receptor represents a ligand-gated cell surface receptor channel that can induce an increase in the SR Ca 2ϩ store and contractile performance independent of L-type Ca 2ϩ channel activation or cAMP accumulation. The contractile characteristics of this receptor channel differ from those of the ␤-or ␣-adrenergic receptor pathways and represent a novel mechanism to augment myocardial SR Ca 2ϩ store and contractility.
